(구)글로벌 핫이슈
방사선종양학
- 2017년 06월호
[Clin Cancer Res. ] Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non-Small Cell Lung Cancer Cell Lines and Tumor Models.Washington University in St. Louis / Dennis E. Hallahan*
- 출처
- Clin Cancer Res.
- 등재일
- 2017 May 15
- 저널이슈번호
- 23(10):2556-2564. doi: 10.1158/1078-0432.CCR-16-1935. Epub 2016 Nov 4.
- 내용
Abstract
Purpose:
Non-small cell lung cancer (NSCLC) and glioblastoma multiforme (GBM) have poor median survival. NSCLC and GBM overexpress glucose regulated protein 78 (GRP78), which has a role in radioresistance and recurrence. In this study, we determined the effect of anti-GRP78 antibody and the combined effect of the anti-GRP78 antibody with ionizing radiation (XRT) on NSCLC and GBM cell lines both in vitro and in vivo
Experimental Design:
NSCLC and GBM cancer cell lines were treated with anti-GRP78 antibodies and evaluated for proliferation, colony formation, cell death, and PI3K/Akt/mTOR signaling. The efficacy of anti-GRP78 antibodies on tumor growth in combination with XRT was determined in vivo in mouse xenograft models.
Results:
GBM and NSCLC cells treated with anti-GRP78 antibodies showed attenuated cell proliferation, colony formation, and enhanced apoptosis. GBM and NSCLC cells treated with anti-GRP78 antibodies also showed global suppression of PI3K/Akt/mTOR signaling. Combining antibody with XRT resulted in significant tumor growth delay in both NSCLC and GBM heterotopic tumor models.
Conclusions:
Antibodies targeting GRP78 exhibited antitumor activity and enhanced the efficacy of radiation in NSCLC and GBM both in vitro and in vivo GRP78 is a promising novel target, and anti-GRP78 antibodies could be used as an effective cancer therapy alone or in combination with XRT.
Author information
Dadey DYA1,2, Kapoor V1, Hoye K3, Khudanyan A1, Collins A1, Thotala D4,5, Hallahan DE4,6,5.
1 Department of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri.
2 Medical Scientist Training Program, Washington University in St. Louis, St. Louis, Missouri.
3 Medical Guidance Systems, St. Louis, Missouri.
4 Department of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri. dhallahan@wustl.edu dthotala@wustl.edu.
5 Siteman Cancer Center, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
6 Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri.
- 덧글달기
- 이전글 [ Lancet Oncol.] Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
- 다음글 [J Clin Oncol.] Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.